Additionally, CXCL6, together with other immune modulators such as CXCL8 and IL-8, contributes to the formation of an immunosuppressive microenvironment that facilitates tumor escape from immune surveillance, thereby promoting cancer progression and resistance to therapy (Fernandez-Avila et al., 2023). This evidence concerns the gene CXCL8 and cancer.